Horton, C., Davies, T., Lahiri, P., Sachamitr, P., & Fairchild, P. (2019). iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. Wiley.
芝加哥风格引文Horton, C., TJ Davies, P. Lahiri, P. Sachamitr, 与 PJ Fairchild. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.
MLA引文Horton, C., et al. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.
警告：这些引文格式不一定是100％准确.